SANOFI AVENTIS US FDA Approval ANDA 062303

ANDA 062303

SANOFI AVENTIS US

FDA Drug Application

Application #062303

Application Sponsors

ANDA 062303SANOFI AVENTIS US

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL150MG0RIFADINRIFAMPIN

FDA Submissions

UNKNOWN; ORIG1AP1981-07-15UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1992-07-24
LABELING; LabelingSUPPL3AP1992-07-24
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1995-10-23
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1994-08-18
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1995-10-23

Submissions Property Types

SUPPL2Null0
SUPPL5Null0
SUPPL6Null0
SUPPL8Null0

TE Codes

001PrescriptionAB

CDER Filings

SANOFI AVENTIS US
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62303
            [companyName] => SANOFI AVENTIS US
            [docInserts] => ["",""]
            [products] => [{"drugName":"RIFADIN","activeIngredients":"RIFAMPIN","strength":"150MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"RIFADIN","submission":"RIFAMPIN","actionType":"150MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.